SAREPTA THERAPEUTICS INC SRPT
June 14, 2015 - 12:34pm EST by
member
| 2015 | 2016 | ||||||
| Price: | 27.69 | EPS | -4.88 | -3.7 | |||
| Shares Out. (in M): | 41 | P/E | 0 | 0 | |||
| Market Cap (in $M): | 1,139 | P/FCF | 0 | 0 | |||
| Net Debt (in $M): | -139 | EBIT | 0 | 0 | |||
| TEV (in $M): | 1,000 | TEV/EBIT | 0 | 0 | |||
Description
| show sort by |
You are not eligible to view 69 messages. To gain access to more recent message posts signup free for membership.
| 116 | |
I think majik is recovering. Probably not a secret that @given2tweet might be similar person so you can get an idea what he is thinking. Congrats to all who stuck with this one. | |
| 113 | |
any update given the news yesterday? TIA. what would the stock price be in various scenarios. ty | |
| 112 | |
My views from posts #107 and #109 still stand. Further, we are now ~10 weeks since FDA asked SRPT for dystrophin data. FDA has had it for 4-6 weeks is my guess. If the samples... login to read the rest | |
| 111 | |
I think the FDA knew they were going to change the protocol to the trial and actually told them to do it and get enrollment under way before #AA is granted.
SRPT had to issue the... login to read the rest | |
| 109 | |
Beat goes on...SRPT releases a PR for the patient community talking about ESSENCE changes. In the PR, they mention ESSENCE is a confirmatory trial for Etep #AA (should it be granted). BAIRD thinks a decision... login to read the rest | |
| 102 | |
Edward -
Pretty speachless as well. I have not sold but have not added. I'm waiting for the voting questions.
Nothing good in the docs besides safety being fine. Even worse, they imply the current P3... login to read the rest | |
| 101 | |
I’m closing out. Was wrong.
While the voting questions aren’t out, the briefing docs basically said SRPT has been lying about various things. And, there really wasn’t anything good to say, at all, except safety. No... login to read the rest | |
| 99 | |
I believe they come Wed morning pre-market but some of the bafoons on yahoo think they come Tuesday. Edward?
I looked at 3 different situations and they both came exactly 2 business days before the | |
| 96 | |
Hi,
You are correct that was a terrible call by me (although if you actually did the hedge I suggested, it wasn’t a big loss).
As Majic said, for the most part SRPT has tracked the biotech... login to read the rest | |
| 95 | |
Didn't take it as an insult especially since I didn't say it.
What I'm saying is Edwards post was made before a 25-30% drop in biotechs so I would adjust those price targets accordingly and thus | |
| 94 | |
don't take it the wrong way - I was just referring to the share price level edward himself named so - no insult meant. | |
| 93 | |
Pretty unfair here to say this has approached his "wrong on everything"...biotechs have been slaughtered since Edward wrote that post so you have to adjust for that.
My thoughts from post 90 remain the same.
Also,... login to read the rest | |
| 88 | |
I agree that 65% is madness, but I have noted that VIC-ers have downplayed two recent evolutions regarding the FDA:
- A recognition that errors of omission can be as bad as errors of comission. The... login to read the rest | |
| 81 | |
Try the March 45/50 spread for maybe 1.75 if you want more time.
The Jan spreads are a bet on bmrn doing poorly AND fund repositioning early 2016.
Not sure if BMRN is a short, but could... login to read the rest | |
| 79 | |
Banafa: Two comments to your questions (which Majic already answered to the extent they needed to be answered but still…)
First comment, question: ¨Parent pressure¨
I think the BMRN AdCom briefing docs has shown that the FDA... login to read the rest | |
| 76 | |
I simply copy and pasted my views from Twitter where the audience knows a lot more about this story than you might. If I offended you I deeply apologize. | |
| 74 | |
Because BMRN filed for approval 2 months before SRPT. There is nothing more to it than that. | |
| 71 | |
Also posted on twitter but again locked account:
Not sure how people can say the Drisa briefing docs were bad but "could have been worse". Really? They essentially say all 3 trials failed and that there... login to read the rest | |
| 70 | |
I posted this on twitter but have a locked acccount so am posting it here too.
Some thoughts from the document as I read it. I am going to leave out things that have already been... login to read the rest | |
| 66 | |
Excellent call on the dec options. I went out to Jan to give myself more time in case the docs weren't as bad as they were but these docs really were all Srpt could ask... login to read the rest | |
| 64 | |
BMRN briefing docs out.
While I still expect a positive AdCom vote (barely), the docs were bad. Below are some quotes, I´m still going through them.
It is greatly concerning that a number of biomarker studies suggest... login to read the rest | |
| 63 | |
No real idea.
A sell side report questioned whether either drug would be approved.
However I believe today was seen as the last day to lower risk before the bmrn events. Lots of weekly put buying and... login to read the rest | |
| 60 | |
Hi Edward
Agree, a big part of my delta adj position is Jan 25 and 30 calls (short 35 and 40 against) in spreads I put in in fall of 2014. I didn't bother mentioning that... login to read the rest | |
| 51 | |
Btw, I had stated before I was holding off redeploying the capital from selling the Jan calls (when stock at $30), but today am fully back in in the low 24s. I realize I have... login to read the rest | |
| 49 | |
Edward:
Excellent job here. I still have a massive position and bought more yesterday (though it's nowheren near as big as a % as it was at it's peak the last 3 years which was after... login to read the rest | |
| 47 | |
I have a few thoughts I would like to throw out there. Neither should be taken as trading recommendations as I haven't changed my long position and for that matter, have not been able to trade this stock to... login to read the rest | |
| 46 | |
Tyler – to answer your point, agree the Jan 40s have some value, I just don´t know how much as I don´t know how to handicap the events for January. Definitely a reasonable possibility the... login to read the rest | |
| 43 | |
Edward, I disagree that the Jan options have no event. They have the BMRN adcom and PDUFA date. Hopefully, this will shed some light on the likelihood of Etep approval. I can't count all the... login to read the rest | |
| 41 | |
AdCom now late Jan. if you have Jan calls I´d sell now, there are a nasty loss, about 45% from the writeup but higher if bought recently. Stock is a different story, worth keeping but | |
| 37 | |
It was the right thing to do, and expected within a week of the wms per my prior post. Sure, they could have waited and maybe saved 3% dilution but what happens if the ceo... login to read the rest | |